Background
WHO’s Product Development for Vaccines Advisory Committee (PDVAC) meetings were convened virtually over the course of 2020 with each meeting covering a particular subject matter. The meetings included:
- Review of Preferred Product Characteristics (PPCs) and Target Product Profiles (TPPs), 22 April 2020
- Update from the Burden of Enteric Diseases working group, 11 May 2020
- Full Value of Vaccine Assessment (FVVA) for Shigella vaccines, 18 May 2020
- Update on development of Enterotoxigenic E.coli (ETEC) vaccines, 18 June 2020
- Update on the Vaccine Innovation Prioritisation Strategy (VIPS), 8 July 2020
- Update on Tuberculosis Vaccines, 3 September 2020
- Update on Gonococcal vaccines, 4 December 2020
Executive summaries of the meetings as well as the agenda, list of participants and presentations can be found below:
Review of PPCs and TPPs, 22 April 2020
Note that other materials are not posted as this was a closed PDVAC session.
Burden of Enteric Diseases, 11 May 2020
Full Value of Vaccine Assessment for Shigella vaccines, 18 May 2020
Update on development of ETEC vaccines, 18 June 2020
Update on the Vaccine Innovation Prioritisation Strategy (VIPS), 8 July 2020
Update on Tuberculosis Vaccines, 3 September 2020
Update on Gonococcal vaccines, 4 December 2020